ALBERT DAVID LIMITED
Latest filings
- Routine compliance certificate submitted to SEBI under Reg 74(5) · Compliance
- Trading window closed from Oct 1 for Q2 FY26-27 results · Compliance
- Newspaper reminder for re-lodgement of physical share transfers · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹364 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
ALBERTDAVD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from ALBERT DAVID LIMITED's filed financials and exchange disclosures
What does ALBERT DAVID LIMITED do?
ALBERT DAVID LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol ALBERTDAVD.
Is ALBERT DAVID LIMITED profitable?
Yes. Over the trailing twelve months ALBERT DAVID LIMITED reported a net profit of ₹23 Cr on revenue of ₹364 Cr.
Does ALBERT DAVID LIMITED pay a dividend?
Yes. The dividend yield is 0.64% at the current price.
Is ALBERT DAVID LIMITED debt-free?
No. It reported borrowings of ₹28 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹28 Cr after cash. Debt stands at 0.07× equity. That is lower than 58% of its 166 Pharmaceuticals peers.
Is ALBERT DAVID LIMITED expensive compared with its peers?
On trailing P/E, ALBERT DAVID LIMITED ranks 45 of 158 in Pharmaceuticals — cheaper than 72% of them, against an industry median of 31.2×. This is a position, not a valuation judgement.
How much does the ALBERT DAVID LIMITED share price move in a day?
On a typical session ALBERT DAVID LIMITED moves 0.86% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.
Where can I track ALBERT DAVID LIMITED's announcements?
Every NSE and BSE filing by ALBERT DAVID LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.